Home/Filings/4/0001867096-24-000168
4//SEC Filing

Pieper Steven 4

Accession 0001867096-24-000168

CIK 0001867096other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 4:06 PM ET

Size

21.8 KB

Accession

0001867096-24-000168

Insider Transaction Report

Form 4
Period: 2022-01-29
Pieper Steven
See Remarks
Transactions
  • Tax Payment

    Common Stock

    2022-07-28$1.43/sh9,767$13,9671,612,935 total
  • Tax Payment

    Common Stock

    2023-01-03$1.12/sh23,067$25,8351,589,868 total
  • Tax Payment

    Common Stock

    2023-01-29$1.26/sh3,590$4,5231,586,278 total
  • Tax Payment

    Common Stock

    2023-01-31$1.24/sh778$9651,585,500 total
  • Tax Payment

    Common Stock

    2023-07-28$2.53/sh10,200$25,8061,575,300 total
  • Tax Payment

    Common Stock

    2024-01-03$2.24/sh23,067$51,6701,552,233 total
  • Tax Payment

    Common Stock

    2024-01-29$2.66/sh4,379$11,6481,547,854 total
  • Tax Payment

    Common Stock

    2024-01-31$2.46/sh110,750$272,4451,437,104 total
  • Tax Payment

    Common Stock

    2024-07-28$2.61/sh14,767$38,5421,422,337 total
  • Tax Payment

    Common Stock

    2022-01-31$2.11/sh750$1,5831,622,702 total
  • Tax Payment

    Common Stock

    2022-01-29$2.11/sh3,460$7,3011,623,452 total
Footnotes (12)
  • [F1]This transaction is being reported late due to administrative oversight.
  • [F10]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.
  • [F11]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.
  • [F12]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of July 28, 2024.
  • [F2]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January, 29, 2022.
  • [F3]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2022.
  • [F4]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of July 28, 2022.
  • [F5]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2023.
  • [F6]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2023.
  • [F7]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023.
  • [F8]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of July 28, 2023.
  • [F9]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.

Issuer

Xeris Biopharma Holdings, Inc.

CIK 0001867096

Entity typeother

Related Parties

1
  • filerCIK 0001875714

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:06 PM ET
Size
21.8 KB